Signals Blog
Menu

Right Turn: Boldly going where no one has gone before

More than 450 people were in Toronto, Canada, this week to attend the 2015 Till & McCulloch Meetings. As you would expect from Canada’s premier stem cell conference, there was great science, interesting debates, multiple awards, talks by industry and lots of...

Update from the Clinic: September

Welcome to your Update from the Clinic for the month of September. OncoSec Medical released some initial data from its Phase 1/2 study investigating ImmunoPulse IL-12 DNA in a rare skin cancer. Pluristem and the National Institute of Allergy and Infectious Diseases...

Right Turn: Stem cell flash mobs and old favourites

If you are a loyal reader of Right Turn (thank you!) then you will know that I scour the Internet looking for unique, thought-provoking, clever, peculiar (with a mega star thrown in to the mix), educational, funny, odd, intriguing – I could go on – items to feature....

Studying the brain needs an “open mind”

Another in the series: “What Drives Research in the Field of Biomaterials?” The amazingly complex system of the brain, and its network of many different cell types interacting and functioning together, has always been “top of mind” – pardon the pun – for many...

Cell Therapy Deal Review: September

. Welcome to your Cell Therapy Deal Review for the month of September. Aduro Biotech went the way of Juno and Kite and bought an antibody discovery platform. Intrexon and ZIOPHARM entered into an agreement to develop a novel Treg-based immunotherapy for GvHD. Kite...